HeartSciences Inc. today announced that the United States Patent and Trademark Office (USPTO) has granted a foundational US patent. This patent covers the estimation of measures of heart function using an ECG, which are critical for the diagnosis and early detection of heart disease. This development further expands HeartSciences’ patent portfolio.
The newly granted patent enhances the company's intellectual property value and provides protection for its innovative AI-powered medical technology. This patent is central to HeartSciences' mission of transforming ECGs to improve their clinical utility for earlier detection of heart disease.
Securing this foundational patent strengthens HeartSciences' competitive advantage in the rapidly evolving AI-ECG market. It underscores the proprietary nature of its technology, which aims to provide diagnostic information related to cardiac dysfunction that has traditionally required cardiac imaging.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.